Tiny eye implant offers hope for tough glaucoma cases

NCT ID NCT07350200

Completed Disease control Sponsor: Military Institute od Medicine National Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a small implant called XEN in 150 people whose glaucoma was still out of control despite previous surgeries. The implant was placed in the eye to help drain fluid and lower pressure. Researchers tracked eye pressure, vision changes, and how many medications patients needed over the long term.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: XEN glaucoma implant (a tiny drainage device placed in the eye to lower pressure)
What this could lead to: If successful, this implant could help people with difficult-to-control glaucoma avoid further vision loss and reduce their need for daily eye drops.
What could go wrong: This is a completed observational study, not a controlled trial, so results may not apply to everyone. The implant carries risks like infection, inflammation, or scarring that can limit its effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA

Contacts and locations

Locations

Military Institute of Medicine - National Research Institute

Warsaw, 04-141, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.